These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3712158)

  • 21. Prognosis of coronary arterial lesions in Kawasaki disease treated without intravenous immunoglobulin.
    Tzen KT; Wu MH; Wang JK; Lue HC; Lee CY; Chien SC
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1997; 38(1):32-7. PubMed ID: 9066187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of coronary abnormalities due to Kawasaki disease in urban area with small Asian population.
    Shulman ST; McAuley JB; Pachman LM; Miller ML; Ruschhaupt DG
    Am J Dis Child; 1987 Apr; 141(4):420-5. PubMed ID: 3565328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Importance of anatomical dominance in the evaluation of coronary dilatation in Kawasaki disease.
    Dionne A; Hanna B; Trinh Tan F; Desjardins L; Lapierre C; Déry J; Fournier A; Dahdah N
    Cardiol Young; 2017 Jul; 27(5):877-883. PubMed ID: 27640521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Echocardiographic diagnosis and clinical observation of coronary lesions in Kawasaki disease].
    Yanagisawa M
    Nihon Rinsho; 1983 Sep; 41(9):2086-91. PubMed ID: 6663744
    [No Abstract]   [Full Text] [Related]  

  • 25. Follow-up study of coronary artery lesions due to Kawasaki disease by serial selective coronary arteriography in 200 patients.
    Suzuki A; Kamiya T; Ono Y; Kohata T; Kimura K; Takamiya M
    Heart Vessels; 1987; 3(3):159-65. PubMed ID: 3440782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Angiographic evaluation of coronary artery lesions due to Kawasaki disease-natural history and coronary artery obstruction].
    Takahashi N
    Fukuoka Igaku Zasshi; 1995 Mar; 86(3):92-8. PubMed ID: 7750895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repeated quantitative angiograms in coronary arterial aneurysm in Kawasaki disease.
    Nakano H; Ueda K; Saito A; Nojima K
    Am J Cardiol; 1985 Nov; 56(13):846-51. PubMed ID: 4061324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effective use of echocardiography in children with Kawasaki disease.
    Scott JS; Ettedgui JA; Neches WH
    Pediatrics; 1999 Nov; 104(5):e57. PubMed ID: 10545583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noninvasive visualization of coronary arterial aneurysm in infants and young children with mucocutaneous lymph node syndrome with two dimensional echocardiography.
    Hiraishi S; Yashiro K; Kusano S
    Am J Cardiol; 1979 Jun; 43(6):1225-33. PubMed ID: 443180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of unresponsiveness to standard high-dose gamma globulin therapy in Kawasaki disease].
    Tavli V; Yilmazer MM; Güven B; Meşe T; Oner T; Demirpençe S
    Turk Kardiyol Dern Ars; 2010 Jan; 38(1):20-4. PubMed ID: 20215838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coronary artery dimensions may be misclassified as normal in Kawasaki disease.
    de Zorzi A; Colan SD; Gauvreau K; Baker AL; Sundel RP; Newburger JW
    J Pediatr; 1998 Aug; 133(2):254-8. PubMed ID: 9709715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cardiologic evaluation of Kawasaki disease: study protocol].
    Maroto E; Rodríguez Cimadevilla JC; García-Dorado D; García EJ
    Rev Esp Cardiol; 1987; 40(5):327-32. PubMed ID: 3454970
    [No Abstract]   [Full Text] [Related]  

  • 33. Mucocutaneous lymph node syndrome: clinical, hemodynamic and angiographic features of coronary obstructive disease.
    Nakanishi T; Takao A; Nakazawa M; Endo M; Niwa K; Takahashi Y
    Am J Cardiol; 1985 Mar; 55(6):662-8. PubMed ID: 3976508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intracoronary thrombolytic therapy in Kawasaki disease and the usefulness of two-dimensional echocardiography in detecting intracoronary thrombi].
    Ichinose E; Kato H; Inoue O; Hirata K; Eto Y; Yoshioka F
    J Cardiogr; 1985 Mar; 15(1):79-87. PubMed ID: 4067350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regression of coronary aneurysms in patients with Kawasaki syndrome.
    Takahashi M; Mason W; Lewis AB
    Circulation; 1987 Feb; 75(2):387-94. PubMed ID: 3802442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myocardial contrast echocardiography of coronary artery lesions due to Kawasaki disease.
    Kinoshita Y; Suzuki A; Nakajima T; Ono Y; Arakaki Y; Kamiya T; Beppu S
    Heart Vessels; 1994; 9(5):254-62. PubMed ID: 7814302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does Abciximab enhance regression of coronary aneurysms resulting from Kawasaki disease?
    Williams RV; Wilke VM; Tani LY; Minich LL
    Pediatrics; 2002 Jan; 109(1):E4. PubMed ID: 11773572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac sequelae of Kawasaki disease among recurrent cases.
    Nakamura Y; Yanagawa H; Ojima T; Kawasaki T; Kato H
    Arch Dis Child; 1998 Feb; 78(2):163-5. PubMed ID: 9579161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility of exercise stress echocardiography for the follow-up of children with coronary involvement secondary to Kawasaki disease.
    Pahl E; Sehgal R; Chrystof D; Neches WH; Webb CL; Duffy CE; Shulman ST; Chaudhry FA
    Circulation; 1995 Jan; 91(1):122-8. PubMed ID: 7805193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequelae of Kawasaki disease in adolescents and young adults.
    Burns JC; Shike H; Gordon JB; Malhotra A; Schoenwetter M; Kawasaki T
    J Am Coll Cardiol; 1996 Jul; 28(1):253-7. PubMed ID: 8752822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.